Bausch Health Companies Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $8.8B | $8.1B | $8.4B |
| Operating income | $1.8B | $1.5B | $963.0M | $454.0M | $450.0M |
| Cash from operations | $1.4B | $1.6B | $1.0B | -$728.0M | $1.4B |
| Capital expenditure | $397.0M | $337.0M | $215.0M | $218.0M | $269.0M |
| Free cash flow | $1.0B | $1.3B | $817.0M | -$946.0M | $1.2B |
| Impairments | $8.0M | $29.0M | $54.0M | $15.0M | $234.0M |
| Total assets | $26.4B | $26.5B | $27.4B | $25.7B | $29.2B |
| Total liabilities | $26.0B | $26.8B | $27.4B | $25.4B | $29.2B |
| Total debt | $20.2B | $20.5B | $21.0B | $19.1B | $22.9B |
Shares outstanding 373.5M
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.